IL6 and gastric cancer: IL-6 is a key mediator of cancer-related inflammation[21];high plasma levels of IL-6 were shown to predict a poor prognosis in patients with gastric cancer.[4] Collecting these evidences, the important role in inflammatory response might be the potential mechanism for the observed association of cytokines with gastric cancer progression in the present study.